内镜发现对CRS控制状态的影响及阈值与长期结局预测
这项前瞻性队列研究纳入188例成人CRS术后患者,在术后6-12个月和18-60个月评估。内镜发现与同期控制状态仅弱相关,但MLK评分添加至V1控制状态(阈值MLK≥3)可 marginal 改善对V2控制的预测(AUC 0.744 vs 0.721)。
要点
- 内镜发现与同期CRS控制状态仅弱相关,总MLK评分优于任一单项成分。
- MLK≥3作为阈值加入V1控制状态可 marginal 改善对V2控制的预测。
- 提供首个真实世界证据支持内镜发现作为CRS疾病进展预测指标。
核心结论
- 内镜发现与同期CRS控制状态仅弱相关,但添加内镜特征可增强对后续V2结局的预测。
- MLK阈值≥3对未来维持控制显示中等预测准确性。
研究设计与样本
- 前瞻性队列研究,纳入2017至2023年接受双侧内镜鼻窦手术的188例成人CRS患者。
- 术后6-12个月(V1)和18-60个月(V2)评估SNOT-22症状、MLK内镜评分和用药情况。
主要发现
- 内镜发现与同期控制状态弱相关,总MLK的AUC在V1为0.631(p<0.001),V2为0.620(p<0.05)。
- 总MLK在关联强度上优于任何单项MLK成分。
- 将MLK(阈值≥3)加入V1控制状态预测V2控制,AUC为0.744,而仅用V1控制状态为0.721(均p<0.001)。
关键数值与推荐
- CRS控制状态基于EPOS 2020标准(不含内镜特征)分为控制或次优控制(部分/未控制)。
- MLK阈值≥3用于增强预测。
临床怎么用
- 在CRS术后评估中可考虑纳入MLK内镜评分,尤其MLK≥3时提示需关注未来控制状态。
- 内镜发现不应单独用于判定同期控制状态,但可作为长期结局的辅助预测工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: EPOS 2020 defined chronic rhinosinusitis (CRS) disease control using patient symptoms and medication usage but endoscopic findings were considered optional. The effect of adding endoscopic features, an appropriate threshold, and their association with present or future symptom control have not been studied. METHODS: A prospective cohort study of 188 adult CRS patients undergoing bilateral endoscopic sinus surgery from 2017 to 2023 was conducted. Patients were assessed at 6-12 months (V1) and 18-60 months (V2) postoperatively. Individual patient symptoms from the SNOT-22, endoscopic findings (modified Lund-Kennedy [MLK] score), and medication usage were recorded. CRS control status was classified as controlled or suboptimal control (EPOS partly/un-controlled) based on EPOS 2020 criteria without endoscopic features. The predictive role of endoscopic findings was analyzed. RESULTS: Endoscopic findings were weakly associated with concurrent control status but the total MLK (V1 AUC = 0.631, p < 0.001; V2 AUC = 0.620, p < 0.05) outperformed any individual MLK component in strength of association. Adding MLK to V1 control status using a threshold of MLK ≥ 3 marginally improved prediction accuracy for V2 control compared to V1 control status defined without endoscopic features (AUC = 0.744 vs. 0.721, respectively, both p < 0.001). CONCLUSION: While endoscopic findings are only weakly associated with concurrent control status, their addition enhances prediction of subsequent V2 CRS outcomes. Our study provides the first real-world evidence supporting the value of endoscopic findings as predictors for CRS disease progression, with an MLK threshold ≥ 3 showing moderate predictive accuracy for future maintenance of control.
引用
- Liao SC, Agarwal A, Bai J, et al. Effect and Threshold of Endoscopic Findings for CRS Control Status and Long-Term Outcome Prediction. Int Forum Allergy Rhinol. 2025. PMID: 41416791. doi:10.1002/alr.70083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。